Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alport Nephropathy”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Post-approval studies (Phase 4)Looking for participantsNCT06499948
What this trial is testing

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi 34
Not applicableLooking for participantsNCT05927467
What this trial is testing

Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

Who this might be right for
Alport Syndrome
Institut National de la Santé Et de la Recherche Médicale, France 700
Not applicableStudy completedNCT03074357
What this trial is testing

Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.

Who this might be right for
Alport Nephropathy
Novartis Pharmaceuticals 68
Not applicableEnded earlyNCT01602835
What this trial is testing

Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

Who this might be right for
Alport Syndrome
Novartis Pharmaceuticals 80
Large-scale testing (Phase 3)Study completedNCT03019185
What this trial is testing

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL

Who this might be right for
Alport Syndrome
Biogen 187
Early research (Phase 1)Study completedNCT03373786
What this trial is testing

RG-012 in Subjects With Alport Syndrome

Who this might be right for
Alport Syndrome
Genzyme, a Sanofi Company 4
Testing effectiveness (Phase 2)Study completedNCT00309257
What this trial is testing

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Who this might be right for
Alport Syndrome
Mario Negri Institute for Pharmacological Research 9
Testing effectiveness (Phase 2)Study completedNCT05267262
What this trial is testing

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Alport SyndromeFocal Segmental Glomerulosclerosis
River 3 Renal Corp. 43
Not applicableStudy completedNCT01696253
What this trial is testing

Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study

Who this might be right for
Alport Syndrome
University of Minnesota 360
Testing effectiveness (Phase 2)UnknownNCT05448755
What this trial is testing

ELX-02 in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Eloxx Pharmaceuticals, Inc. 8
Not applicableStudy completedNCT01465126
What this trial is testing

Enalapril in Collagen Type 4 Nephropathy

Who this might be right for
Collagen Type-4 Nephropathies
University of Sao Paulo 19
Not applicableLooking for participantsNCT06526741
What this trial is testing

ASF Alport Patient Registry

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseHereditary Nephritis
Alport Syndrome Foundation 2,500
Not applicableLooking for participantsNCT04947813
What this trial is testing

Genotype-Phenotype Correlations in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 8,165
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731192
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome

Who this might be right for
Alport Syndrome
Guangzhou Women and Children's Medical Center 40
Not applicableNot Yet RecruitingNCT05133050
What this trial is testing

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Who this might be right for
Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT02136862
What this trial is testing

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Who this might be right for
Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
Genzyme, a Sanofi Company 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07211685
What this trial is testing

BAY3401016; Biomarker Study Alport

Who this might be right for
Alport Syndrome
Bayer 60
Testing effectiveness (Phase 2)Ended earlyNCT02855268
What this trial is testing

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Genzyme, a Sanofi Company 43
Load More Results